Zobrazeno 1 - 10
of 90
pro vyhledávání: '"J H, Simon"'
Autor:
N. A. Simonian, J H Simon, Roy W. Beck, T J Murray, Lawrence Jacobs, Alfred Sandrock, P J Slasor, C. M. Brownscheidle, R. P. Kinkel
Publikováno v:
New England Journal of Medicine. 343:898-904
Background Treatment with interferon beta has been shown to help patients with established multiple sclerosis, but it is not known whether initiating treatment at the time of a first clinical demyelinating event is of value. Methods We conducted a ra
Autor:
J H, Simon
Publikováno v:
General dentistry.
C-shaped canal configurations present special clinical problems including relief of pain, copious bleeding, and difficulty in cleaning, shaping, and filling. A review of the literature, radiographic characteristics that make diagnosis possible before
Publikováno v:
AJNR Am J Neuroradiol
MR imaging has been a critical element in multiple sclerosis care because it has been the basis, along with clinical measures, for testing treatment efficacy. MR imaging serves as a primary outcome measure in phase II and a secondary outcome measure
Autor:
J Szumowski, J H Simon, Allan J. Fox, Donald H. Lee, David M. Pelz, Thomas E. Feasby, S J Karlik
Publikováno v:
Radiology. 179:543-546
A derivative of the Dixon method, chopper fat suppression, was used in the magnetic resonance imaging evaluation of 40 patients: 37 with suspected optic nerve lesions, predominantly optic neuritis, and three with orbital lesions. In patients with opt
Publikováno v:
Acta Radiologica. 31:209-212
The glucose metabolism effects of six hour exposures to subarachnoid injections of metrizamide, iohexol, iodixanol and control solutions were studied in vivo in 18 rabbits. The brain tissue uptake of intravenously injected 14C labelled deoxyglucose w
Publikováno v:
Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis ISBN: 9788847021716
T1 -hypointense lesions (T1-black holes) in multiple sclerosis (MS) are areas of relatively severe central nervous system (CNS) damage compared with the more non-specific T2-hyperintense lesions, which show greater signal intensity than normal brain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d34384376d4cb0bbd3f8b7374d8f87bc
https://doi.org/10.1007/978-88-470-2117-4_14
https://doi.org/10.1007/978-88-470-2117-4_14
Autor:
R A, Rudick, D E, Goodkin, L D, Jacobs, D L, Cookfair, R M, Herndon, J R, Richert, A M, Salazar, J S, Fischer, C V, Granger, J H, Simon, J J, Alam, N A, Simonian, M K, Campion, D M, Bartoszak, D N, Bourdette, J, Braiman, C M, Brownscheidle, M E, Coats, S L, Cohan, D S, Dougherty, R P, Kinkel, M K, Mass, F E, Munschauer, R L, Priore, P M, Pullicino, B J, Scherokman, B, Weistock-Guttman, R H, Whitham
Publikováno v:
Neurology. 57(12 Suppl 5)
Autor:
J H, Simon
Publikováno v:
Neuroimaging clinics of North America. 10(4)
Until recently, atrophy of the brain and spinal chord was thought to occur late in the course of multiple sclerosis (MS) or as a result of rare, fulminant disease. Now atrophy is known to occur early and likely indicates destructive and irreversible
Autor:
J S, Fischer, R L, Priore, L D, Jacobs, D L, Cookfair, R A, Rudick, R M, Herndon, J R, Richert, A M, Salazar, D E, Goodkin, C V, Granger, J H, Simon, J H, Grafman, M D, Lezak, K M, O'Reilly Hovey, K K, Perkins, D, Barilla-Clark, M, Schacter, D W, Shucard, A L, Davidson, K E, Wende, D N, Bourdette, M F, Kooijmans-Coutinho
Publikováno v:
Annals of neurology. 48(6)
Cognitive dysfunction is common in multiple sclerosis (MS), yet few studies have examined effects of treatment on neuropsychological (NP) performance. To evaluate the effects of interferon beta-1a (IFNbeta-1a, 30 microg administered intramuscularly o
Autor:
L D, Jacobs, R W, Beck, J H, Simon, R P, Kinkel, C M, Brownscheidle, T J, Murray, N A, Simonian, P J, Slasor, A W, Sandrock
Publikováno v:
The New England journal of medicine. 343(13)
Treatment with interferon beta has been shown to help patients with established multiple sclerosis, but it is not known whether initiating treatment at the time of a first clinical demyelinating event is of value.We conducted a randomized, double-bli